CpG Diagnostics
Techstars '24Pasadena, US · 1 known investors
CpG Diagnostics develops epigenetic diagnostic technology to detect cancer through analysis of methylation changes, with an initial focus on ovarian cancer. The platform aims to enable earlier and more accurate diagnosis for gynecologic malignancies.
AI & Machine LearningBiotechDigital HealthMedical Devices